Telescope Innovations Corp. (TELI.CN)

CAD 0.29

(0.0%)

Net Debt Summary of Telescope Innovations Corp.

  • Telescope Innovations Corp.'s latest annual net debt in 2022 was -719.49 Thousand CAD , up 78.16% from previous year.
  • Telescope Innovations Corp.'s latest quarterly net debt in 2023 Q2 was -1.71 Million CAD , down -2.9% from previous quarter.
  • Telescope Innovations Corp. reported annual net debt of -3.29 Million CAD in 2021, down -17888.27% from previous year.
  • Telescope Innovations Corp. reported annual net debt of 18.52 Thousand CAD in 2020, down 0.0% from previous year.
  • Telescope Innovations Corp. reported quarterly net debt of -1.71 Million CAD for 2023 Q2, down -2.9% from previous quarter.
  • Telescope Innovations Corp. reported quarterly net debt of -275.79 Thousand CAD for 2023 Q3, up 83.95% from previous quarter.

Annual Net Debt Chart of Telescope Innovations Corp. (2022 - 2019)

Historical Annual Net Debt of Telescope Innovations Corp. (2022 - 2019)

Year Net Debt Net Debt Growth
2022 -719.49 Thousand CAD 78.16%
2021 -3.29 Million CAD -17888.27%
2020 18.52 Thousand CAD 0.0%
2019 18.52 Thousand CAD 0.0%

Peer Net Debt Comparison of Telescope Innovations Corp.

Name Net Debt Net Debt Difference
Algernon Pharmaceuticals Inc. -125.08 Thousand CAD -475.203%
Asep Medical Holdings Inc -44.72 Thousand CAD -1508.848%
BetterLife Pharma Inc. 207.85 Thousand CAD 446.16%
BioVaxys Technology Corp. -977.00 CAD -73543.091%
ChitogenX Inc. 3.84 Million CAD 118.737%
Rapid Dose Therapeutics Corp. 2.29 Million CAD 131.383%
Defence Therapeutics Inc. 1.68 Million CAD 142.576%
Entheon Biomedical Corp. -344.63 Thousand CAD -108.771%
Gemina Laboratories Ltd. 284.33 Thousand CAD 353.043%
Glow Lifetech Corp. 116.15 Thousand CAD 719.452%
Lexston Life Sciences Corp. -390.4 Thousand CAD -84.294%
Pharmala Biotech Holdings Inc. 58.49 Thousand CAD 1330.008%
Doseology Sciences Inc. -1.06 Million CAD 32.138%
MYND Life Sciences Inc. 2.99 Million CAD 123.985%
Nova Mentis Life Science Corp. -8088.00 CAD -8795.809%
PharmaTher Holdings Ltd. -2.13 Million CAD 66.272%
PreveCeutical Medical Inc. 3.83 Million CAD 118.772%